OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
3,362,560
Share change
+679,736
Total reported value
$45,395,000
Price per share
$13.50
Number of holders
43
Value change
+$9,266,357
Number of buys
25
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q4 2018

As of 31 Dec 2018, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,362,560 shares. The largest 10 holders included Vanguard Group Inc, Cloverdale Capital Management, LLC, GABELLI FUNDS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, QS Investors, LLC, EAM Global Investors LLC, and GAMCO INVESTORS, INC. ET AL. This page lists 43 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.